Cargando…
Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma‐derived human FXIII concentrate in animals
Factor XIII (FXIII) is a coagulation protein which plays a major role in hemostasis by covalently cross‐linking fibrin molecules, thereby stabilizing the blood clot and increasing resistance to fibrinolysis. FXIII deficiency, either congenital or acquired, is associated with spontaneous bleeding, in...
Autores principales: | Beyerle, Andrea, Solomon, Cristina, Dickneite, Gerhard, Herzog, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804322/ https://www.ncbi.nlm.nih.gov/pubmed/27069637 http://dx.doi.org/10.1002/prp2.227 |
Ejemplares similares
-
Cellular FXIII in Human Macrophage-Derived Foam Cells
por: Somodi, Laura, et al.
Publicado: (2023) -
Recombinant FXIII (rFXIII-A
(2)
) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency
por: Carcao, Manuel, et al.
Publicado: (2018) -
Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models
por: Ghosh, Subhajit, et al.
Publicado: (2021) -
Successful treatment of intractable pseudomeningocele with FXIII deficiency by surgery and FXIII replacement therapy: A case report
por: Takamatsu, Nobutoshi, et al.
Publicado: (2022) -
Nonclinical Pharmacokinetic and Pharmacodynamic Assessment of Bimatoprost Following a Single Intracameral Injection of Sustained-Release Implants
por: Shen, Jie, et al.
Publicado: (2020)